• 1
    Zmeili OS, Soubani AO. Pulmonary aspergillosis: a clinical update. QJM 2007; 100: 31734.
  • 2
    Trof RJ, Beishuizen A, Debets-Ossenkopp YJ et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med. 2007; 33: 1694703.
  • 3
    Cornet M, Mallat H, Somme D et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients—a two-case report. Clin. Microbiol. Infect. 2003; 9: 12247.
  • 4
    Wickramasinghe D, Perera B, Perera P. Invasive pulmonary aspergillosis in an immunocompetent patient. Galle Med. J. 2009; 11: 623.
  • 5
    Díaz Sánchez C, López Viña A. Pulmonary aspergillosis. Arch. Bronconeumol. 2004; 40: 11422.
  • 6
    Pathak V, Hurtado Rendon IS, Ciubotaru RL. Invasive pulmonary aspergillosis in an immunocompetent patient. Respir. Med. CME 2011; 4: 1056.
  • 7
    De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008; 46: 181321.
  • 8
    Yan X, Li M, Jiang M et al. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 2009; 115: 501825.
  • 9
    Cornet M, Fleury L, Maslo C et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J. Hosp. Infect. 2002; 51: 28896.
  • 10
    Wald A, Leisenring W, van Burik JA et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 1997; 175: 145966.
  • 11
    Panagopoulou P, Filioti J, Petrikkos G et al. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J. Hosp. Infect. 2002; 52: 18591.
  • 12
    Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44: S27S72.
  • 13
    Reichenberger F et al. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur. Respir. J. 2001; 19: 74355.
  • 14
    Meersseman W, Vandecasteele SJ, Wilmer A et al. Invasive aspergillosis in critically ill patients without malignancy. Am. J. Respir. Crit. Care Med. 2004; 170: 62125.
  • 15
    Vandewoude KH, Blot SI, Depuydt P et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit. Care 2006; 10: R31.
  • 16
    Greene RE, Schlamm HT, Stark P et al. Radiological findings in acute invasive pulmonary aspergillosis: utility and reliability of halo sign and air-crescent sign for diagnosis and treatment of invasive pulmonary aspergillosis in high-risk patients. Clin. Microbiol. Infect. 2003; 9: O397.
  • 17
    Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 2001; 32: 35866.
  • 18
    Vandewoude KH, Blot SI, Benoit D et al. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J. Hosp. Infect. 2004; 56: 26976.
  • 19
    Ribrag V, Dreyfus F, Venot A et al. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. Leuk. Lymphoma 1993; 10: 31721.
  • 20
    Yeghen T, Kibbler CC, Prentice HG et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin. Infect. Dis. 2000; 31: 85968.
  • 21
    Nivoix Y, Velten M, Letscher-Bru V et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin. Infect. Dis. 2008; 47: 117684.
  • 22
    Lipman ML, Goldstein E. Serum lactic dehydrogenase predicts mortality in patients with AIDS and Pneumocystis pneumonia. West. J. Med. 1988; 149: 4867.
  • 23
    Benson CA, Spear J, Hines D et al. Combined APACHE II score and serum lactate dehydrogenase as predictors of in-hospital mortality caused by first episode Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Am. J. Respir. Crit. Care Med. 1991; 144: 31923.
  • 24
    Couppié P, Sobesky M, Aznar C et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin. Infect. Dis. 2004; 38: 13438.
  • 25
    Eigentler TK, Figl A, Krex D et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011; 117: 1697703.
  • 26
    Konjević G, Jurisić V, Jakovljević B et al. Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors. Glas. Srp. Akad. Nauka. Med. 2002; 47: 13747.
  • 27
    Zhou GQ, Tang LL, Mao YP et al. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. Int. J. Radiat. Oncol. Biol. Phys. 2011; 82: e35965.
  • 28
    Wimazal F, Sperr WR, Kundi M et al. Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes. Ann. Oncol. 2008; 19: 9706.
  • 29
    Hafiz MG, Rahman MM, Mannan MA. Serum lactate dehydrogenase as a prognostic marker of childhood acute lymphoblastic leukemia. Mymensingh Med. J. 2008; 17: 16973.
  • 30
    Karlsson M, Wiberg-Itzel E, Chakkarapani E et al. Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr. 2010; 99: 113944.
  • 31
    Zein JG, Lee GL, Tawk M et al. Prognostic significance of elevated serum lactate dehydrogenase (LDH) in patients with severe sepsis. Chest 2004; 126: 873S.
  • 32
    Tárrega J, Jerez FR, Plaza V et al. The prognostic factors of invasive pulmonary aspergillosis in patients with chronic pneumopathy. Arch. Bronconeumol. 2000; 36: 2933.